Insider Sale by Smith Jason Drew (General Counsel)
Trade Summary
2 days ago, Smith Jason Drew, serving as General Counsel at UroGen Pharma Ltd. (URGN), sold 1,519 shares at $42.54 per share, for a total transaction value of $64,618.26. Following this transaction, Smith Jason Drew now holds 53,141 shares of URGN.
This sale represents a 2.78% decrease in Smith Jason Drew's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 2:35 PM ET, 1 day after the trade was made.
UroGen Pharma Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$42.54
Quantity
1,519
Total Value
$64,618.26
Shares Owned
53,141
Trade Date
2 days ago
SEC Filing Date
at 2:35 PM ET
Filed 1 day after trade
Discussion